John B. Henneman III, Director of Anika Therapeutics ANIK, has filed 3 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $134.6K. The latest trade was on 06/18.

JI

JI

John B. Henneman III

Director

Company

Anika Therapeutics ANIK

First filing

23/01/09

Trades

33 trades

Buys / sales

3 / 1

12-month net buying

$134.6K

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Orthofix MedicalOFIX	Open-market buy	05/07	05/08	5,000 sh	$12.26	$61,300	+5.8%
Anika TherapeuticsANIK	Open-market buy	05/01	05/04	5,000 sh	$14.66	$73,300	+10.0%
Aprea TherapeuticsAPRE	Open-market buy	24/03/13	24/03/14	6,860 sh	$7.29	$50,009.4	+536.4%
RR R1 RCM	Open-market sale	23/08/08	23/08/09	50,000 sh	$17.17	$858,500	−40.9%